Validations: Filing-Grade Defensibility & Lifecycle

Effective CAPA for E&L Findings: Durable Fixes

Effective CAPA for E&L Findings: Durable Fixes In the realm of pharmaceuticals, the validation of extractables and leachables (E&L) is crucial for ensuring the safety and efficacy of the product throughout its entire lifecycle. Issues related to E&L can significantly impact product quality, necessitating robust Corrective and Preventive Actions (CAPA). This guide aims to provide a step-by-step tutorial for pharma…

Continue Reading Effective CAPA for E&L Findings: Durable Fixes

Multi-Market Messaging: US vs EU Harmonization

Multi-Market Messaging: US vs EU Harmonization Multi-Market Messaging: US vs EU Harmonization In the pharmaceutical industry, ensuring that products are safe, effective, and compliant with regulations from various regions is paramount. The focus on extractables and leachables (E&L) has gained substantial traction, particularly pertaining to packaging materials and delivery systems. As pharmaceutical companies navigate regulatory landscapes such as the US…

Continue Reading Multi-Market Messaging: US vs EU Harmonization

Use of Modeling in Filings: What’s Acceptable Today

Use of Modeling in Filings: What’s Acceptable Today Use of Modeling in Filings: What’s Acceptable Today The pharmaceutical industry continually strives for improved methodologies in process and product validation, particularly in the context of extractables and leachables (E&L). Understanding what is acceptable in regulatory submissions is essential for ensuring compliance with the stringent expectations from regulatory agencies such as the…

Continue Reading Use of Modeling in Filings: What’s Acceptable Today

Supplier Letters and LOAs: What Works, What Doesn’t

Supplier Letters and LOAs: What Works, What Doesn’t Supplier Letters and LOAs: What Works, What Doesn’t The pharmaceutical industry continually emphasizes the importance of stringent regulatory compliance, especially in the context of extractables and leachables (E&L) and packaging qualification. The complexities involved in ensuring compliance necessitate guidance from suppliers, which often comes in the form of letters and Letters of…

Continue Reading Supplier Letters and LOAs: What Works, What Doesn’t

Audit Trails & Data Integrity in E&L Submissions

Audit Trails & Data Integrity in E&L Submissions Audit Trails & Data Integrity in E&L Submissions The pharmaceutical industry faces increasingly stringent requirements for ensuring the safety and efficacy of medicinal products. An essential aspect of this is the assessment of extractables and leachables (E&L) during the development and manufacturing processes, particularly under the guidelines established by regulatory bodies such…

Continue Reading Audit Trails & Data Integrity in E&L Submissions

Quality Agreements: Validation Clauses for E&L Deliverables

Quality Agreements: Validation Clauses for E&L Deliverables The pharmaceutical industry operates under stringent regulations aimed at ensuring product safety and efficacy. One crucial aspect of this regulatory framework is the management of extractables and leachables (E&L) in drug product packaging and delivery systems. Quality agreements play an essential role in defining responsibilities regarding E&L considerations between stakeholders. This step-by-step guide…

Continue Reading Quality Agreements: Validation Clauses for E&L Deliverables

When to Use PQRI and BPOG Language in Filings

When to Use PQRI and BPOG Language in Filings When to Use PQRI and BPOG Language in Filings Understanding Extractables and Leachables in Pharmaceutical Products Extractables and leachables (E&L) refer to the chemical compounds that may migrate from packaging materials or container closure systems into pharmaceutical products. The migration can occur through various means such as contact and storage conditions….

Continue Reading When to Use PQRI and BPOG Language in Filings

Alignment with ICH M7, Q3D, and Related Standards

Alignment with ICH M7, Q3D, and Related Standards Alignment with ICH M7, Q3D, and Related Standards In the pharmaceutical industry, ensuring the safety and efficacy of drug products is paramount. A critical aspect of this is the qualification of extractables and leachables (E&L) and the implementation of robust analytical evaluation thresholds (AET) and dose-based thresholds (DBT). This comprehensive guide outlines…

Continue Reading Alignment with ICH M7, Q3D, and Related Standards

Human Factors: Training and SME Coaching for E&L Defenses

Human Factors: Training and SME Coaching for E&L Defenses Human Factors: Training and SME Coaching for E&L Defenses Introduction to Extractables and Leachables (E&L) The pharmaceutical industry faces increasing scrutiny regarding the safety and efficacy of drug products, specifically the impact of extractables and leachables (E&L) from packaging materials and device components. This article serves as a comprehensive guide for…

Continue Reading Human Factors: Training and SME Coaching for E&L Defenses

De-Risking Unknowns: Conservative Assumptions and Commitments

De-Risking Unknowns: Conservative Assumptions and Commitments In the realms of pharmaceutical development and manufacturing, ensuring product integrity and patient safety is paramount. Extractables and leachables (E&L) assessment has become a critical component of this assurance process, especially in validating packaging systems and single-use components. This comprehensive guide is designed to help pharmaceutical professionals implement effective E&L strategies that are both…

Continue Reading De-Risking Unknowns: Conservative Assumptions and Commitments